Rocket Lab's Balancing Act: Insider Exits and a Sector-Defining IPO

Rocket Lab shares are wrestling with two powerful forces pulling in opposite directions — a wave of insider profit-taking and the gravitational pull of SpaceX’s looming public debut. The stock, currently trading around €105.60 in Frankfurt, has shed roughly 18% from the 52-week high of €129.20 reached on May 27, leaving a year-to-date gain of more than 63% intact while a 12-month view shows a staggering 354% advance.

The sell-off gathered pace on Monday when four company insiders sold a combined $18 million worth of equity, cashing in after a torrid rally that produced eight all-time highs in May and a monthly gain of about 55%. That marked Rocket Lab’s best month since November 2024. The pullback has brought the relative strength index to around 51, a neutral reading that suggests the stock is in a genuine consolidation phase rather than a directional breakdown.

Compounding the insider exit is the approaching initial public offering of SpaceX, which is reshaping how the market values the entire space sector. Bloomberg reported that the Elon Musk-led company is targeting a valuation of at least $1.8 trillion, below earlier whispers of $2 trillion — a figure Musk himself disputed. Formal marketing is set to begin on June 4, with pricing potentially following on June 11. For Rocket Lab, the IPO acts as a double-edged sword: it draws capital and attention into the space arena but risks a "sell the news" reaction once SpaceX actually lists.

Rocket Lab’s fundamental story, however, remains robust. First-quarter 2026 revenue hit $200.3 million, a 63.5% jump from a year earlier, with GAAP gross margin of 38.2%. The backlog stands at $2.2 billion, underpinned by more than 70 contracted missions in the startup manifest — including 31 new Electron and HASTE contracts and five dedicated Neutron launches signed in the quarter alone. Management guided second-quarter revenue of $225 million to $240 million, with GAAP gross margins of 33% to 35% and non-GAAP margins of 38% to 40%. Adjusted EBITDA loss is expected between $20 million and $26 million.

Should investors sell immediately? Or is it worth buying Rocket Lab?

A key driver of that growth narrative is the expansion beyond launch services into space systems. Late last month Rocket Lab closed the acquisition of Motiv Space Systems, a specialist in space robotics whose technology flew on NASA’s Mars rover Perseverance. The business, now rebranded as Rocket Lab Robotics, brings capabilities in motion control, precision mechanisms, and drive systems for solar arrays, antenna gimbals, filter wheels, and focusing mechanisms. The company is weaving these components into its constellation-scale satellite production and high-power orbital infrastructure — including in-space data centers that could require solar systems of 100 kilowatts or more.

Defense and government contracts further bolster the order book. Rocket Lab secured over $1.3 billion in awards from the Space Development Agency, plus a $90 million contract with the U.S. Space Force for two geostationary satellites. These wins reinforce the view that Rocket Lab is the most direct publicly traded proxy for SpaceX’s core businesses: launch vehicles, satellite manufacturing, and national security missions. MarketBeat flagged that status on June 2, calling Rocket Lab a litmus test for the entire sector.

Yet the valuation attached to that proxy leaves little margin for error. The price-to-sales ratio, based on forward estimates, sits at 88.3. Among 18 analysts polled by S&P Global, the average price target works out to about €104 — below the current share price. The range spans from a low of $60 to a high of $150. While most analysts retain buy recommendations, the consensus target suggests the stock is already pricing in a high degree of future success.

Rocket Lab at a turning point? This analysis reveals what investors need to know now.

Options market activity reflects the underlying tension. The put/call ratio stands at 0.66, indicating that bullish bets still outnumber bearish ones, but the annualized 30-day implied volatility of over 130% signals extreme nervousness. On June 2, the stock closed at $122.81 in New York after trading between $122.67 and $128.02 on volume of 12.63 million shares, giving it a market capitalization of roughly $74.35 billion. The price-to-earnings ratio remains negative, meaning the market is betting entirely on growth, execution, and backlog conversion rather than current profitability.

With SpaceX’s IPO timeline now set in motion, the next major price swing for Rocket Lab could materialize within days. The amended SEC filing on June 1 — an S-1/A containing 83 documents — has recalibrated the sector benchmark. For Rocket Lab, the challenge is to demonstrate that its own trajectory of revenue growth, margin discipline, and contract execution can justify the valuation that the SpaceX proxy narrative has already baked in. The next quarterly delivery, due later this summer, will be the first real test of whether the stock can hold its altitude.

Ad

Rocket Lab Stock: New Analysis - 3 June

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

en | US7731211089 | ROCKET | boerse | 69474414 |